StonvexLoading…
StonvexStonvexStonvexCore line items from RLX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $566.11M | $376.55M | $223.44M | $773.18M |
Operating Income | $46.98M | $-14.68M | $-69.96M | $154.18M |
Net Income | $131.83M | $75.60M | $75.26M | $208.96M |
EPS (Diluted) | $0.10 | $0.06 | $0.06 | $0.16 |
Total Assets | $2.56B | $2.31B | $2.30B | $2.37B |
Total Liabilities | $314.31M | $120.71M | $100.94M | $121.57M |
Cash & Equivalents | $767.49M | $766.30M | $336.67M | $183.92M |
Free Cash Flow OCF − CapEx | $141.11M | $115.66M | $24.01M | $64.98M |
Shares Outstanding | 1.22B | 1.29B | 1.34B | 1.53B |